Chugai Selected as “Digital Transformation Stocks (DX Stocks) 2026”
TOKYO, April 10, 2026 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that it has b...
Publisher
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
TOKYO, April 10, 2026 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that it has b...
Source route
Continue on chugai-pharm.co.jp
Leave the platform to read the original full article on the publisher site.
Source: Chugai Pharmaceutical
Scope: Devices
Related coverage
More related coverage
GAP Nail™ Endo-Exo Medullary System
Dreem Health joins Amazon’s Health Benefits Connector
The integration with Amazon presents a means for Amazon customers to enrol and gain access to servic...
Boehringer hands over $50m and market rights for Click’s digital therapeutic
Click's CT-155 commercialisation plan comes as regulatory-approved digital therapeutics experience s...
Waters lands FDA clearance for at-home cervical cancer screening kit
Waters BD Onclarity HPV assay is intended to remove barriers that prevent individuals from receiving...